Nevirapine (Viramune) is a medication that's used as part of an antiretroviral (ARV) regimen to treat human immunodeficiency virus (HIV) infections. It's available in both immediate-release and extended-release formulations. Nevirapine (Viramune) also comes as an oral suspension for people who have trouble swallowing and children. Rarely, this medication can cause severe rash in the first 4 months of treatment. Get medical attention right away if rash happens.
Nevirapine (Viramune) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It blocks a protein in HIV called reverse transcriptase that usually helps the virus make copies of itself. By blocking this protein, nevirapine (Viramune) prevents the HIV virus from spreading.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
If you're taking nevirapine (Viramune) for the first time, your provider will have you begin with a lower starting dose of nevirapine (Viramune) for 2 weeks. This is to help minimize your risk for rash, which is a common side effect of this medication. If you notice a rash within the first 2 weeks, stop taking nevirapine (Viramune) and let your provider know right away. If the rash gets worse, it can lead to liver damage as well. If you don't develop any rash within the first 2 weeks, your provider will raise your dose of nevirapine (Viramune) to a higher maintenance dose.
No, nevirapine (Viramune) isn't meant to be taken alone for HIV, but as a part of a combination antiretroviral therapy (ART). Typically, your provider will prescribe two other medications along with nevirapine (Viramune) to fight the virus and prevent it from spreading. These other medications work differently from nevirapine (Viramune) to help lower the amount of virus in the body (viral load). Lowering the HIV viral load helps keep your immune system working. Nevirapine (Viramune) alone isn't enough to fight HIV and taking it on its one can make your infection more difficult to treat. Talk to your provider if you've questions about what HIV ART medications should be a part of your treatment plan.
No, nevirapine (Viramune) isn't FDA-approved to be used for post-exposure prophylaxis (PEP) to prevent HIV infection after you've been exposed. Medications for PEP might be given to someone who have been exposed to HIV through sex or sharing needles. PEP medications are typically given within 72 hours of exposure. Nevirapine (Viramune) isn't recommended to be used for PEP since it has caused severe liver damage, including liver failure, in people without HIV. Talk to your provider about best PEP options for you.
Let your provider know if you're pregnant or thinking of getting pregnant. They can discuss with you about the risks and benefits of taking nevirapine (Viramune). Clinical guidelines recommend that pregnant people with HIV start treatment as soon as possible to lower the risk of transferring the virus to the unborn baby. But nevirapine (Viramune) hasn’t been well studied in human pregnancies. Some studies showed that this medication can raise the risk of severe liver problems when mothers take it during pregnancy. The risk is also higher in mothers with high levels of CD4 cells (white blood cells). If you're pregnant and you're taking nevirapine (Viramune), you’re encouraged to enroll in the Antiretroviral Pregnancy Registry (APR). This registry collects information about your and your baby’s health during treatment with nevirapine (Viramune). You can learn more about this registry by calling 1-800-258-4263.
Maybe. Nevirapine (Viramune) has been shown to lower the levels of estrogen and certain progesterone (norethindrone) when taken together, which might cause them to not work as well. Even though this combination hasn't been shown to raise the risk for pregnancy in clinical studies, talk with your provider if you're concerned about getting pregnant during treatment. Always use a condom as an additional form of birth control. Aside from preventing pregnancy, most condoms work well in preventing HIV transmission.
Nevirapine (Viramune) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Nevirapine (Viramune) can cause life-threatening liver problems that might lead to liver failure and the need for a liver transplant. These problems are more common in the first 4 months of treatment. If you've a history of moderate to severe liver problems, don't take nevirapine (Viramune). Your provider'll ask you to get blood tests done before and during treatment to check your liver health. If you have any of the risk factors, please talk with your provider so they can decide how you can safely take nevirapine (Viramune).
People who develop liver problems in the first 4 months of treatment might experience rash along with symptoms of liver injury. If you experience signs and symptoms of liver damage, such as feeling sleepy, nausea, loss of appetite, light-colored stool, upper right stomach pain, yellowing of the skin or eyes, or dark urine, talk with your provider immediately.
Nevirapine (Viramune) can cause severe skin reactions and allergic reactions that are sometimes life-threatening. Most people who developed skin reactions did so within the first 6 weeks of treatment. The risk for these reactions is the greatest within the first 4 months. This is why it's important to start with a lower dose of nevirapine (Viramune) so your provider can see how you tolerate this medication. Watch out for allergic reactions. If you experience a severe rash with fever, general discomfort, muscle or joint pain, mouth sores, blisters, or facial swelling, stop taking nevirapine (Viramune) right away and get medical attention.
If you have a serious allergic reaction, your provider will probably switch you to a different medication to treat HIV. Your provider might also check your liver health through blood work since severe allergic reactions can sometimes lead to liver injury.
Taking combination ARV therapy, such as nevirapine (Viramune) with other HIV medications, can cause changes to your immune system called immune reconstitution syndrome. This medical condition happens when your immune system becomes more active after you start combination therapy. Your immune system begins to fight off different infections that it was too weak to fight off before you started treatment. In rare cases, your immune response might improve so much with treatment that it starts to attack normal cells in your body (autoimmune). You can develop immune reconstitution syndrome as early as during the first few weeks of treatment or many months later. Tell your healthcare provider right away if you start having any new symptoms, such as fever, pain, hair loss, bulging eyes, or sweating, after starting nevirapine (Viramune).
Rarely, people taking HIV medications, such as nevirapine (Viramune), have experienced changes in body fat. These changes include fat buildup in the back of the neck, breast, and around the middle of your body. Some people also lost fat from the legs, arms, and face. It's not clear whether nevirapine (Viramune) causes these changes to body fat, why this happens, and whether it will affect your health in the future. Let your provider know if these changes occur while you're taking nevirapine (Viramune).
Some medications can interfere with how well your body gets rid of nevirapine (Viramune) from your system. This can affect the amount of nevirapine (Viramune) in your body, how well it works, and the risk of side effects.
Taking certain medications, such as rifampin (Rifadin), can lower the amount of nevirapine (Viramune) in your body. This can make nevirapine (Viramune) not work as well to treat your HIV. On the other hand, taking medications like fluconazole (Diflucan) can raise the amount of nevirapine (Viramune) in your body and put you at higher risk for serious side effects, such as rash.
Nevirapine (Viramune) also gets in the way of how your body gets rid of other medications. For example, taking nevirapine (Viramune) with medications like clarithromycin can lower the amount of clarithromycin in your body. This can cause your bacterial infection to get worse.
Because of the potential for interactions with nevirapine (Viramune) and various medications, tell your provider and pharmacist about all the medications you take or plan to take. They can make sure your medications are safe to take together.
Nevirapine (Viramune) immediate-release tablet and solution
Nevirapine (Viramune) extended-release tablet
If you're starting nevirapine (Viramune) extended-release tablet for the first time, your provider will have you take nevirapine (Viramune) immediate-release tablet or oral suspension for 2 weeks first (see dosing above). After that:
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Nevirapine (Viramune) will not be safe for you to take.